Literature DB >> 27429964

Surgical pathology of early stage non-small cell lung carcinoma.

Mary Beth Beasley1, Francine R Dembitzer1, Raja M Flores2.   

Abstract

The histologic classification of non-small cell lung carcinoma (NSCLC), particularly adenocarcinoma (ADC), has undergone extensive study in recent decades, ultimately resulting in an extensively updated classification system. The 2015 World Health Organization (WHO) classification of ADC provides greatly improved prognostic information in comparison to the 2004 WHO classification. Several issues still require further investigation: lepidic predominant ADC, prognostic significance of poor prognostic subtypes such as micropapillary carcinoma, the more recently described concept of spread of tumor through airspaces (STAS), and the utility of sublobar resections. While limited resection appears to be suitable for tumors with a ground glass radiographic appearance, which typically correspond to adenocarcinoma in situ (MIS) or minimally invasive adenocarcinoma (MIA) histologically, the role of sublobar resection in radiographic solid tumors is not as clear, and the impact of histologic subtypes with a poor prognosis needs further evaluation. Squamous cell carcinoma (SCC) has not been as extensively studied and the current classification lacks subclassification with significant prognostic information.

Entities:  

Keywords:  Adenocarcinoma (ADC); lepidic; micropapillary; solid; spread of tumor through airspaces (STAS); squamous cell carcinoma (SCC)

Year:  2016        PMID: 27429964      PMCID: PMC4930521          DOI: 10.21037/atm.2016.06.13

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  45 in total

1.  Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.

Authors:  Shuji Murakami; Hiroyuki Ito; Norifumi Tsubokawa; Takahiro Mimae; Shinsuke Sasada; Tomoharu Yoshiya; Yoshihiro Miyata; Tomoyuki Yokose; Morihito Okada; Haruhiko Nakayama
Journal:  Lung Cancer       Date:  2015-07-02       Impact factor: 5.705

2.  Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.

Authors:  Geewon Lee; Ho Yun Lee; Ji Yun Jeong; Joungho Han; Min Jae Cha; Kyung Soo Lee; Jhingook Kim; Young Mog Shim
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

3.  Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.

Authors:  Yang Zhang; Yihua Sun; Yunjian Pan; Chenguang Li; Lei Shen; Yuan Li; Xiaoyang Luo; Ting Ye; Rui Wang; Haichuan Hu; Hang Li; Lei Wang; William Pao; Haiquan Chen
Journal:  Clin Cancer Res       Date:  2012-02-08       Impact factor: 12.531

4.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Authors:  Arne Warth; Thomas Muley; Michael Meister; Albrecht Stenzinger; Michael Thomas; Peter Schirmacher; Philipp A Schnabel; Jan Budczies; Hans Hoffmann; Wilko Weichert
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

5.  Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.

Authors:  Junji Yoshida; Kanji Nagai; Tomoyuki Yokose; Mitsuyo Nishimura; Ryutaro Kakinuma; Hironobu Ohmatsu; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

6.  Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator.

Authors:  Akiko Miyagi Maeshima; Naobumi Tochigi; Akihiko Yoshida; Hisao Asamura; Koji Tsuta; Hitoshi Tsuda
Journal:  J Thorac Oncol       Date:  2010-03       Impact factor: 15.609

7.  Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.

Authors:  Alain C Borczuk; Fang Qian; Angeliki Kazeros; Jennifer Eleazar; Adel Assaad; Joshua R Sonett; Mark Ginsburg; Lyall Gorenstein; Charles A Powell
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

8.  Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma.

Authors:  Kazunori Kamiya; Yuichiro Hayashi; Junya Douguchi; Akinori Hashiguchi; Taketo Yamada; Yotaro Izumi; Masazumi Watanabe; Masafumi Kawamura; Hirohisa Horinouchi; Naoki Shimada; Koichi Kobayashi; Michiie Sakamoto
Journal:  Mod Pathol       Date:  2008-05-30       Impact factor: 7.842

9.  Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Authors:  Noriko Motoi; Janos Szoke; Gregory J Riely; Venkatraman E Seshan; Mark G Kris; Valerie W Rusch; William L Gerald; William D Travis
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

10.  Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.

Authors:  Yi-Chen Yeh; Jun-ichi Nitadori; Kyuichi Kadota; Akihiko Yoshizawa; Natasha Rekhtman; Andre L Moreira; Camelia S Sima; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Histopathology       Date:  2015-02-05       Impact factor: 5.087

View more
  4 in total

Review 1.  A narrative review of prognosis prediction models for non-small cell lung cancer: what kind of predictors should be selected and how to improve models?

Authors:  Yuhang Wang; Xuefeng Lin; Daqiang Sun
Journal:  Ann Transl Med       Date:  2021-10

2.  Surgery without preoperative histological confirmation of lung cancer: what is the current clinical practice?

Authors:  Mohammad R Ghamati; Wilson W L Li; Erik H F M van der Heijden; Ad F T M Verhagen; Ronald A Damhuis
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

3.  Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.

Authors:  Wen-Ting Huang; Wei-Luan Cen; Rong-Quan He; You Xie; Yu Zhang; Ping Li; Ting-Qing Gan; Gang Chen; Xiao-Hua Hu
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

4.  Early stage lung cancer: pathologist's perspective.

Authors:  Francesca Boggio; Alessandro Del Gobbo; Giorgio Croci; Marco Barella; Stefano Ferrero
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.